Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of Xprenor versus Subutex in opioid-dependent patients
2012-003560-49Phase 2Completed
- Sponsor
- Macarthys Laboratories
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of buprenorphine in opioid use disorder (OUD) (2 arms), sponsored by Macarthys Laboratories. Primary endpoints: Safety and Pharmacokinetics. Started Aug 2012; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2012-003560-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003560-49.